Peritoneal Fibrosis: Clinical Trials

1 trial for Peritoneal Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Peritoneal Fibrosis: new trials by email Literature Review of Peritoneal Fibrosis trials Research Report on Peritoneal Fibrosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Canagliflozin on Ultrafiltration & Fibrosis in Patients on Peritoneal Dialysis
Canagliflozin 300 MG - ESRD, CKD (Chronic Kidney Disease) Stage 5D
Phase 2RecruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre302026-02-012026-03-16

Narrower conditions

Kidney Failure, Chronic (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Chronic Disease (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Fibrosis (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peritoneal Diseases (1)  ·  Renal Insufficiency (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Canagliflozin (1)

Sponsors

McGill University Health Centre/Research Institute of the McGill University Health Centre (1)

Countries

Canada (1)

Top investigators

Thomas A. Mavrakanas, MD, MSc. (1)

NIH funding

2025 (1)